These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7022175)

  • 41. Some factors affecting mutant numbers in the Salmonella/microsome assay.
    Booth SC; Welch AM; Garner RC
    Carcinogenesis; 1980; 1(11):911-23. PubMed ID: 11219844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J; Kobayashi Y; Monden S; Suzuki S
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative transformation of 2-acetylaminofluorene by a chemical model for cytochrome P450: A water-insoluble porphyrin and tert-butyl hydroperoxide.
    Inami K; Mochizuki M
    Bioorg Med Chem; 2008 Jul; 16(14):7070-7. PubMed ID: 18586499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimum S9 concentrations in bacterial mutagenicity assays.
    Forster R; Green MH; Priestley A
    Adv Exp Med Biol; 1981; 136 Pt B():1263-9. PubMed ID: 7046386
    [No Abstract]   [Full Text] [Related]  

  • 45. Enhancement of the mutagenicity of 2-acetylaminofluorene by flavonoids and the structural requirements.
    Ogawa S; Hirayama T; Sumida Y; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1987 Feb; 190(2):107-12. PubMed ID: 3547114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium.
    Meinl W; Meerman JH; Glatt H
    Pharmacogenetics; 2002 Dec; 12(9):677-89. PubMed ID: 12464797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotoxicity of N-acetylarylamines in the salmonella/hepatocyte system.
    Thorgeirsson SS; Erickson LC; Smith CL; Glowinski IB
    Environ Health Perspect; 1983 Mar; 49():141-5. PubMed ID: 6339222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acrylamide as an inducer of metabolic activation system (S9) in rats.
    el-Din AY; al-Maskati HA; Mohamed AY; Dairi MG
    Mutat Res; 1993 Jul; 300(2):91-7. PubMed ID: 7685498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay.
    McGregor DB; Edwards I; Riach CG; Cattanach P; Martin R; Mitchell A; Caspary WJ
    Mutagenesis; 1988 Nov; 3(6):485-90. PubMed ID: 3070287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal neurulation induced by 7-hydroxy-2-acetylaminofluorene and acetaminophen: evidence for catechol metabolites as proximate dysmorphogens.
    Harris C; Stark KL; Luchtel DL; Juchau MR
    Toxicol Appl Pharmacol; 1989 Dec; 101(3):432-46. PubMed ID: 2603160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
    Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT; White GL; Heflich RH; Beland FA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagenicity testing of some commonly used dyes.
    Chung KT; Fulk GE; Andrews AW
    Appl Environ Microbiol; 1981 Oct; 42(4):641-8. PubMed ID: 7039509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 32P-post-labeling method in quantitative DNA adduct dosimetry of 2-acetylaminofluorene-induced mutagenicity in Chinese hamster ovary cells and Salmonella typhimurium TA1538.
    Arce GT; Cline DT; Mead JE
    Carcinogenesis; 1987 Apr; 8(4):515-20. PubMed ID: 3549038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The suppressive effect of hepatic 9,000 x G supernatant fraction from 3-methylcholanthrene-treated rats on the mutagenic activity of 2-acetylaminofluorene.
    Kojima A; Kawano S; Hiraga K
    Jpn J Pharmacol; 1980 Aug; 30(4):421-6. PubMed ID: 7206358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative toxicity and mutagenicity of N-hydroxy-2-acetylaminofluorene and 7-acetyl-N-hydroxy-2-acetylaminofluorene in human lymphoblasts.
    Babson JR; Gavitt NE; Boteju LW; Hanna PE
    Mutat Res; 1992 Sep; 269(1):73-8. PubMed ID: 1381473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity.
    Shah AB; Combes RD; Rowland IR
    Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methodology for the testing of food dyes for genotoxic activity: experiments with red 2G (C.I. 18050).
    Haveland-Smith RB; Combes RD; Bridges BA
    Mutat Res; 1979 Aug; 64(4):241-8. PubMed ID: 384228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.